Deciphera Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Deciphera Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $20.79 million as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2024-02-07
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $20.79M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $15.00K.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $3.10M.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $104.89M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2023-12-31 | $20.79M 10-K · filed 2024-02-07 |
| 2022-12-31 | $15.00K 10-K · filed 2023-02-07 |
| 2021-12-31 | $3.10M 10-K · filed 2022-02-08 |
| 2020-12-31 | $104.89M 10-K · filed 2021-02-09 |
| 2019-12-31 | $157.59M 10-K · filed 2020-03-09 |
| 2018-12-31 | $53.74M 10-K · filed 2019-03-14 |
| 2017-12-31 | $47.43M 10-K · filed 2018-03-28 |